# Basal Plus GLP1-ra on Glycemic Variability in CKD

> **NCT05218915** · PHASE4 · COMPLETED · sponsor: **Elaine Chow** · enrollment: 95 (actual)

## Conditions studied

- Diabetes Mellitus
- Diabetic Kidney Disease

## Interventions

- **DRUG:** Dulaglutide
- **DRUG:** Insulin Degludec
- **DEVICE:** Continuous glucose monitor

## Key facts

- **NCT ID:** NCT05218915
- **Lead sponsor:** Elaine Chow
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-28
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2024-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05218915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05218915, "Basal Plus GLP1-ra on Glycemic Variability in CKD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05218915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*